1-methyl-3-isobutylxanthine has been researched along with mianserin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Neal, BS; Sparber, SB | 2 |
Messing, RB; Neal, BS; Sparber, SB | 1 |
Battista, PJ; Condon, WA; Rexroad, CE | 1 |
Kleven, MS; Sparber, SB | 1 |
Curtis-Prior, PB; Tan, S | 1 |
7 other study(ies) available for 1-methyl-3-isobutylxanthine and mianserin
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
The serotonin2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Conditioning, Operant; Male; Mianserin; Morphine Dependence; Naloxone; Piperidines; Rats; Reinforcement Schedule; Ritanserin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1990 |
Long-term effects of neonatal exposure to isobutylmethylxanthine. I. Retardation of learning with antagonism by mianserin.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Body Weight; Cognition; Conditioning, Operant; Exploratory Behavior; Female; Learning; Mianserin; Rats; Reinforcement Schedule | 1991 |
Long-term effects of neonatal exposure to isobutylmethylxanthine. II. Attenuation of acute morphine withdrawal in mature rats.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Body Temperature; Conditioning, Operant; Dose-Response Relationship, Drug; Mianserin; Morphine; Naloxone; Rats; Receptors, Opioid; Reinforcement Schedule; Substance Withdrawal Syndrome | 1991 |
Mechanisms involved in the action of serotonin-induced stimulation of progesterone production by bovine luteal cells in vitro.
Topics: 1-Methyl-3-isobutylxanthine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cattle; Corpus Luteum; Estrus; Female; In Vitro Techniques; Ketanserin; Mianserin; Progesterone; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1987 |
Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.
Topics: 1-Methyl-3-isobutylxanthine; 5-Hydroxytryptophan; Animals; Fluoxetine; Male; Methysergide; Mianserin; Morphine; Piperidines; Rats; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1989 |
Comparative effects of RX 781094, mianserin, yohimbine, rauwolscine and prazosin in reversing clonidine inhibition of MIX-stimulated lipolysis in hamster isolated white fat cells.
Topics: 1-Methyl-3-isobutylxanthine; Adipose Tissue; Adrenergic alpha-Antagonists; Animals; Clonidine; Cricetinae; Dioxanes; Epididymis; Idazoxan; In Vitro Techniques; Lipolysis; Male; Mianserin; Prazosin; Theophylline; Yohimbine | 1984 |